Randomized trials of amifostine and radiotherapy: Effect on survival?

Seminars in Oncology

Volumn 31, Issue SUPPL. 18, 2004, Pages 62-66

  Bourhis, J ^a,c   Thephamongkhol, K ^b   Pignon, J P ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Department of Radiotherapy ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL PROTECTION; CLINICAL TRIAL; CONFERENCE PAPER; DATA BASE; DRUG EFFECT; EMBASE; HEAD AND NECK CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MEDLINE; META ANALYSIS; PELVIS CANCER; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZATION; SIDE EFFECT; SURVIVAL; TREATMENT OUTCOME;

EID: 13844270809     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.12.015     Document Type: Conference Paper

References (36)

1. M.I. Koukourakis Amifostine in clinical oncology Current use and future applications Anticancer Drugs 13 2002 181 209
2. J.C. Lindergaard, C. Grau Has the outlook improved for amifostine as a clinical radioprotector? Radiother Oncol 57 2000 113 118
3. J.P. Pignon, C. Hill Meta-analysis of randomised clinical trials in oncology Lancet Oncol 2 2001 475 482
4. J. Bourhis, N. Syz, J. Overgaard Conventional vs modified fractionated radiotherapy. Meta-analysis of radiotherapy in head & neck carcinoma: A meta-analysis based on individual patient data Int J Radiat Oncol Biol Phys 54 SUPPL. 2002 71 72
5. J.P. Pignon, J. Bourhis, C. Domenge MACH-NC Collaborative Group Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma Three meta-analyses of updated individual data Lancet 255 2000 949 955
6. Early Breast Cancer Trialists' Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women Lancet 339 1992 1-15-71-85
7. A. Auperin, R. Arriagada, J.P. Pignon Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission N Engl J Med 341 1999 476 484
8. The Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer A meta-analysis using updated individual patient data from 56 randomised clinical trials BMJ 311 1995 899 909
9. C.B. Begg, J.A. Berlin Publication bias and the dissemination of clinical research J Natl Cancer Inst 81 1989 107 115
10. L.A. Stewart, M.K.B. Parmar Meta-analysis of the literature or of individual data Is there a difference? Lancet 341 1993 418 422
11. D. Antonadou Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer Sem Radiat Oncol 12 SUPPL. 1 2002 50 58
12. D. Antonadou, N. Coliarakis, M. Syndodinou Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer Int J Radiat Oncol Biol Phys 51 2001 915 922
13. D. Antonadou, N. Throuvalas, A. Pertridis Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 57 2003 402 408
14. M.I. Koukourakis, G. Kyrias, S. Kakolyris Subcutaneous administration of amifostine during fractionated radiotherapy A randomized phase II study J Clin Oncol 18 2000 2226 2233
15. R. Komaki, J.S. Lee, B. Kaplan Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer Preliminary results Semin Radiat Oncol 12 SUPPL. 1 2002 46 49
16. R. Komaki, J.S. Lee, L. Milas Effect of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer Report of a randomized comparative trial Int J Radiat Oncol Biol Phys 58 2004 1369 1377
17. S.S. Leong, E.H. Tan, K.W. Fong Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer J Clin Oncol 21 2003 1767 1774
18. B. Movsas Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer Radiation Therapy Oncology Group Trial 98-01 Semin Radiat Oncol 12 SUPPL. 1 2002 40 45
19. M. Werner-Wasik, C. Scott, B. Movsas Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT) Results of the Radiation Therapy Oncology Group (RTOG) 98-01 study Int J Rad Oncol Biol Phys 57 SUPPL. 2003 S216 (abstr)
20. N. Senzer A phase III randomized evaluation of amifostine in stage IIIA/ IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification Preliminary findings Semin Oncol 29 SUPPL. 19 2002 38 41
21. D.M. Brizel, T.H. Wasserman, M. Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 2000 3339 3345
22. T. Wasserman, J.I. Mackowiak, D.M. Brizel Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer Int J Radiat Oncol Biol Phys 48 2000 1035 1039
23. V. Rudat, J. Meyer, F. Momm Protective effect of amifostine on dental health after radiotherapy of the head and neck Cancer 48 2000 1339 1343
24. J. Bourhis, R. De Crevoisier, B. Abdulkarim A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 46 2000 1105 1108
25. V. Veerasarn, P. Phromratanapongse, N. Suntornpong Effect of amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function Eur J Cancer 1 SUPPL. 2003 S273 (abstr)
26. D. Antonadou, M. Pepelassi, M. Synodinou Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer Int J Radiat Oncol Biol Phys 52 2002 739 747
27. J. Buntzel, M. Glatzel, K. Kuttner Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer Semin Radiat Oncol 12 SUPPL. 1 2002 4 13
28. C.L. Bennett, D. Lane, T. Stinson Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer Preliminary results from a randomized phase II clinical trial from Germany Cancer Invest 19 2001 107 113
29. J. Buntzel, A. Monnier, J. Ammon Phase III randomized double blind placebo controlled trial of carboplatin and radiation therapy ± amifostine in patients with head and neck cancer Int J Radiat Oncol Biol Phys 51 SUPPL. 1 2001 85 (abstr)
30. P. Vacha, F. Fehleuer, B. Mahlmann Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer Is there evidence for radioprotection? Strahlenther Onkol 179 2003 385 389
31. M. Braaksma, P. Levendag, M. De Jonge Organ preservation with chemoradiation in advanced head and neck cancer concomitant paclitaxel with or without subcutaneous amifostine prior to radiation preliminary results on toxicity of a randomized clinical trial Int J Rad Oncol Biol Phys 54 SUPPL. 2002 291 (abstr)
32. R. Giglio, E. Mickiewicz, E. Pradier Alternating chemotherapy (CT) + radiotherapy (RT) with amifostine (A) protection for head and neck cancer (HN). Early stop of a randomized trial Proc Am Soc Clin Oncol 116 1997 384a (abstr 1369)
33. H. Athanassiou, D. Antonadou, N. Coliarakis Oncology Hellenic Group Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas Results of a randomized trial Int J Radiat Oncol Biol Phys 56 2003 1154 1160
34. J. Kouvaris, V. Kouloulias, E. Malas Amifostine as radioprotector agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy Strahlenther Onkol 179 2003 167 174
35. D. Antonadou, H. Athanassiou, G. Sarris Randomized phase III trial of chemoradiation treatment +/- amifostine in patients with colorectal cancer Proc Am Soc Clin Oncol 22 2003 293 (abstr 1176)
36. D. Gallardo, A. Mohar, G. Calderillo Cisplatin, radiation and amifostine in carcinoma of the uterine cervix Int J Gynecol Cancer 9 1999 225 230